Calcitriol Treatment Decreases Cell Migration, Viability and β-Catenin Signaling in Oral Dysplasia
Open Access
- 2 April 2024
- journal article
- research article
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 46 (4) , 3050-3062
Abstract
Nearly 90% of oral cancers are characterized as oral squamous cell carcinoma (OSCC), representing the sixth most common type of cancer. OSCC usually evolves from oral potentially malignant disorders that, in some cases, are histologically consistent with a oral dysplasia. The levels of 1α,25 dihydroxyvitamin D3 (1,25-(OH)2D3; calcitriol), the active form of vitamin D3, have been shown to be decreased in patients with oral dysplasia and OSCC. Moreover, treatment with 1,25-(OH)2D3 has been proven beneficial in OSCC by inhibiting the Wnt/β-catenin pathway, a signaling route that promotes cell migration, proliferation, and viability. However, whether this inhibition mechanism occurs in oral dysplasia is unknown. To approach this question, we used dysplastic oral keratinocyte cultures and oral explants (ex vivo model of oral dysplasia) treated with 1,25-(OH)2D3 for 48 h. Following treatment with 1,25-(OH)2D3, both in vitro and ex vivo models of oral dysplasia showed decreased levels of nuclear β-catenin by immunofluorescence (IF) and immunohistochemistry (IHC). Consistently, reduced protein and mRNA levels of the Wnt/β-catenin target gene survivin were observed after treatment with 1,25-(OH)2D3. Moreover, 1,25-(OH)2D3 promoted membranous localization of E-cadherin and nuclear localization of vitamin D receptor (VDR). Functionally, DOK cells treated with 1,25-(OH)2D3 displayed diminished cell migration and viability in vitro.Keywords
Funding Information
- National Fund for Scientific and Technological Development FONDECYT (11221000, 11240983, 1220517, UI-024/19, PRI-ODO 19-01, ICN09_016/ICN 2021_045)
- Vice-rectory for Research and Development (VID) at Universidad de Chile (11221000, 11240983, 1220517, UI-024/19, PRI-ODO 19-01, ICN09_016/ICN 2021_045)
This publication has 42 references indexed in Scilit:
- Impact of dietary vitamin D on initiation and progression of oral cancerThe Journal of Steroid Biochemistry and Molecular Biology, 2020
- Nuclear localization of β-catenin and expression of target genes are associated with increased Wnt secretion in oral dysplasiaOral Oncology, 2019
- Role of vitamin D and vitamin D receptor (VDR) in oral cancerBiomedicine & Pharmacotherapy, 2019
- Management update of potentially premalignant oral epithelial lesionsOral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 2018
- Analysis of images for detection of oral epithelial dysplasia: A reviewOral Oncology, 2018
- Reciprocal role of vitamin D receptor on β-catenin regulated keratinocyte proliferation and differentiationThe Journal of Steroid Biochemistry and Molecular Biology, 2014
- Wnt/β-Catenin Signaling and DiseaseCell, 2012
- High prevalence of vitamin D insufficiency in patients with head and neck cancer at diagnosisHead & Neck, 2012
- Nuclear vitamin D receptor expression is associated with improved survival in non-small cell lung cancerThe Journal of Steroid Biochemistry and Molecular Biology, 2011
- Treatment With 1-Alpha,25-Dihydroxyvitamin D3 (Vitamin D3) to Inhibit Carcinogenesis in the Hamster Buccal Pouch ModelJAMA Otolaryngology–Head & Neck Surgery, 2007